ctrl K

Price Alert

Caladrius Biosciences Inc... (CLBS)

NASDAQ: CLBS · Real-Time Price · USD

0.43

-0.08 (-16.05%)

At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	125.59M	125.59M	125.59M	25.23M	25.23M	25.23M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	125.59M	125.59M	125.59M	25.23M	25.23M	25.23M
Operating Income	-27.05M	-27.62M	-28.97M	-27.61M	-26.01M	-23.09M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-27.05M	-27.62M	-28.97M	-27.61M	-26.01M	-23.09M
Net Income	-24.57M	-23.63M	-27.47M	-26.1M	-24.5M	-12.22M
Selling & General & Admin	12.37M	11.7M	11.37M	11.21M	10.69M	10.34M
Research & Development	14.79M	15.88M	17.68M	16.44M	15.34M	12.83M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	27.16M	27.58M	29.05M	27.65M	26.03M	23.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	27.16M	27.58M	29.05M	27.65M	26.03M	23.17M
Income Tax Expense	-971K	-2.48M	n/a	9.36M	9.37M	2K
Shares Outstanding (Basic)	60.53M	60.56M	59.61M	59.61M	59.51M	42.12M
Shares Outstanding (Diluted)	60.53M	60.56M	59.61M	59.61M	59.51M	42.12M
EPS (Basic)	-0.41	-0.4	-0.52	-0.7	-0.87	-0.27
EPS (Diluted)	-0.41	-0.4	-0.52	-0.7	-0.87	-0.27
EBITDA	-27.02M	-27.57M	-28.92M	-27.55M	-25.95M	-23.03M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	36K	46K	55K	64K	66K	64K